GlassScriptPhysician profile
Suruchi S Thakore
NPI 1104052125
$2,888.27
in general payments reported to CMS, 2019-2025
13 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Reproductive Endocrinology provider received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $353 · 2020: $287 · 2021: $593 · 2022: $581 · 2023: $561 · 2024: $347 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055 · Education: $19.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.27 |
| Education | $19.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $970.83 | 2020-2025 | Stripper, Origio Sequential Fert |
| Ferring Pharmaceuticals INC. | $488.33 | 2019-2024 | Menopur |
| Organon LLC | $468.56 | 2021-2024 | Follistim Aq, Pregnyl, Ganirelix Acetate |
| Merck Sharp & Dohme LLC | $287.31 | 2019-2021 | |
| Abbvie INC. | $188.07 | 2019-2023 | Orilissa |
| Hologic INC | $128.29 | 2021 | |
| Emd Serono, INC. | $109.42 | 2019-2025 | |
| Therapeuticsmd, INC. | $98.81 | 2019 | |
| Hologic Sales and Service, LLC | $79.71 | 2020-2022 | |
| Myovant Sciences INC. | $25.17 | 2022 | |
| Cook Medical LLC | $16.14 | 2019 | |
| Minerva Surgical, INC | $15.53 | 2024 | |
| Meditrina | $12.10 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suruchi Thakore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.